1AI — Algorae Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$18.23m
- AU$14.29m
- AU$0.08m
Annual cashflow statement for Algorae Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | R2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.002 | 0.033 | 0.107 | 0.903 | 0.464 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.04 | -1.99 | -1.52 | -0.785 | -2.6 |
| Capital Expenditures | -0.004 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.043 | 0.978 | -0.277 | 0.45 | 1.1 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0.04 | 0.978 | -0.277 | 0.45 | 1.1 |
| Financing Cash Flow Items | 1.83 | -0.299 | -0.049 | -0.003 | -0.157 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.69 | 1.85 | 0.523 | -0.003 | 4.22 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.67 | 0.85 | -1.28 | -0.339 | 2.72 |